Premium
Livedo Reticularis: A Side Effect of Interferon Therapy in a Pediatric Patient with Melanoma
Author(s) -
Fox Michelle,
Tahan Steven,
Kim Caroline C.
Publication year - 2011
Publication title -
pediatric dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 73
eISSN - 1525-1470
pISSN - 0736-8046
DOI - 10.1111/j.1525-1470.2011.01426.x
Subject(s) - medicine , livedo reticularis , melanoma , dermatology , alpha interferon , etiology , interferon , interferon alfa , side effect (computer science) , pathology , immunology , cancer research , disease , computer science , programming language
Livedo reticularis is a lacy mottling of the skin that can have many etiologies. We report a case of an 8‐year‐old boy with a diagnosis of melanoma who developed persistent livedo reticularis during treatment with interferon alpha‐2B. To our knowledge, this is the first case report of livedo reticularis occurring as a side effect of interferon treatment for pediatric melanoma. Given the increasing incidence of pediatric melanoma, it is important that dermatologists be aware of potential side effects of interferon therapy to optimize care and education for these patients.